Skip to content
MarketScale
‹ Back to IndustriesHealthcare

TPC’s Interventional Cardiology (IC) Program Engages in Partnerships That Deliver Greater Value for its Membership

For small, stand-alone hospitals, remaining profitable while providing the best patient care can be challenging. TPC provides a platform for strategic partnerships that can help these independent entities reduce costs and improve patient outcomes. Working collaboratively, TPC Member hospitals achieve more together, collectively negotiating for services and supplies to increase their financial, operational and clinical…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

For small, stand-alone hospitals, remaining profitable while providing the best patient care can be challenging. TPC provides a platform for strategic partnerships that can help these independent entities reduce costs and improve patient outcomes. Working collaboratively, TPC Member hospitals achieve more together, collectively negotiating for services and supplies to increase their financial, operational and clinical performance.

TPC programs deliver opportunities through Member-driven custom contracting, providing access to clinically acceptable products purchased in aggregate to decrease costs. As part of the process, from contract period to contract period, TPC evaluates marketplace opportunities in existing categories, using specific, predetermined criteria to ascertain the most superior products at the best value. By remaining supplier agnostic, TPC Members have the flexibility to comfortably disrupt the status quo and shift between suppliers to drive the highest value back to the membership.

When it comes to PPI, the TPC collaborative model has proven results in reducing supply chain expenses. A highly Member-engaged initiative that has yielded impressive results, TPC’s Interventional Cardiology (IC) program drove $1.2 million in savings across the membership in 2018, representing 11% of total IC spend. And since the IC initiative’s 2010 inception, over $9.98 million has been saved by TPC Members. TPC continues to meet its commitment with the category’s preferred suppliers, with Members maintaining greater than 80% compliance. TPC is the epitome of a value-based partnership of community-based hospitals working together as a single system.

Stronger Together. Superior Results.

To learn more about membership click here.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512